Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE ONSET OF DENERVATION SUPERSENSITIVITY

S. Z. Langer and U. Trendelenburg
Journal of Pharmacology and Experimental Therapeutics January 1966, 151 (1) 73-86;
S. Z. Langer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
U. Trendelenburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The time course of the development of supersensitivity to norepinephrine of the denervated nictitating membrane of the spinal cat was studied between the 16th and 40th hr after denervation of one side and decentralization of the other. Denervation supersensitivity was found to develop just before the degeneration contraction appeared; the former reached nearly maximal values after the latter had passed its maximum. Pretreatment with [2(2,6-dimethylphenoxy)propyl]trimethylammonium chloride monohydrate (β-TM 10) delayed the onset of the degeneration contraction by about 10 hr, and correspondingly delayed the onset of denervation supersensitivity to norepinephrine. The maximum of the degeneration contraction was equivalent to one quarter of maximal shortening of the smooth muscle of the nictitating membrane. Evidence has been presented to show that such increases in tone reduce conventional estimates of supersensitivity. It has also been shown that tone can be determined quantitatively, and that estimates of supersensitivity can be corrected for tone. Dose-response curves for tyramine gave evidence that there is supersensitivity to this amine during the early stages of degeneration of the nerve terminals; tyramine was then found to be more effective than can be attributed to the supersensitivity to norepinephrine. In the later stages of degeneration, the maximal response to tyramine declined, probably because of the loss of norepinephrine from the stores. During early stages of the degeneration contraction there was spontaneous activity in the denervated nictitating membrane. The release of the transmitter during degeneration of adrenergic nerve terminals appears to be discontinuous.

Footnotes

    • Accepted August 26, 1965.
  • The Williams & Wilkins Comapny

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 151, Issue 1
1 Jan 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE ONSET OF DENERVATION SUPERSENSITIVITY
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE ONSET OF DENERVATION SUPERSENSITIVITY

S. Z. Langer and U. Trendelenburg
Journal of Pharmacology and Experimental Therapeutics January 1, 1966, 151 (1) 73-86;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE ONSET OF DENERVATION SUPERSENSITIVITY

S. Z. Langer and U. Trendelenburg
Journal of Pharmacology and Experimental Therapeutics January 1, 1966, 151 (1) 73-86;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Meeting Report for the ASPET–Ray Fuller Symposium: Cellular Mechanisms and Novel Strategies for Pain Control
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics